Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7943778 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Patent 7943778 was granted and assigned to Reata Pharmaceuticals, Inc. on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Reata Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7943778

Date of Patent

May 17, 2011

Patent Application Number

12426832

Date Filed

April 20, 2009

Patent Citations Received

‌

US Patent 12065464 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

‌

US Patent 11919838 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

‌

US Patent 11993574 Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma

‌

US Patent 12060340 Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith

‌

US Patent 11873320 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

‌

US Patent 11911395 Methods of treating obesity using antioxidant inflammation modulators

Patent Primary Examiner

‌

Shawquia Young

Patent abstract

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7943778 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API